Massimo Cristofanilli

Dr. Massimo Cristofanilli is a world-renowned oncologist and precision medicine expert. Massimo currently serves as Scientific Advisor at Olaris, and previously served as President of the International Society of Liquid Biopsy (ISLB), Chair of the Precision Medicine Exchange Consortium (PMEC) Oversight Committee, and Professor of Medicine & Associate Director of Translational Research & Precision Medicine at Northwestern University - The Feinberg School of Medicine. Dr. Cristofanilli has also held positions as Professor of Medical Oncology & Deputy Cancer Center Director for Translational Research at Thomas Jefferson University Hospitals, Chairman of the Medical Oncology Department at Fox Chase Cancer Center, and Associate Professor of Medicine in the Department of Breast Medical Oncology at The University of Texas M.D. Anderson Cancer Center. Throughout their illustrious career, Dr. Cristofanilli has made significant contributions to the field of oncology, helping to improve the lives of countless cancer patients worldwide.

After receiving their Doctor of Medicine from Sapienza Università di Roma, Massimo Cristofanilli pursued a fellowship in medical oncology at The University of Texas M.D. Anderson Cancer Center. Massimo then went on to complete a program for chiefs of clinical services at Harvard T.H. Chan School of Public Health. In addition, they have received certification from the American Board of Internal Medicine in both medical oncology and internal medicine, as well as from the ESMO - European Society for Medical Oncology in medical oncology.